The role of banana lectin in mitigating inflammatory bowel disease

FHS
June 3, 2024
10:35 am

The therapeutic role of recombinant banana lectin (rBanLec) concerning IBD control and raising vaccination rates.

A legendary biotech investor warns that shorting industry stocks isn’t easy

SAN FRANCISCO — “No one ever got really rich shorting stocks,” said Joe Edelman, the founder and CEO of Perceptive Advisors, a $7.5 billion biotech

January 14, 2025

NX-1607 by Nurix Therapeutics for Metastatic Transitional (Urothelial) Tract Cancer: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 28, 2023

Denali reports a PhII ALS fail as RIPK1 deal with Sanofi hits another bump

Sanofi and Denali Therapeutics’ partnership ran into yet another stumbling block after their ALS program failed a Phase II study. DNL788 did not achieve the

February 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.